196 related articles for article (PubMed ID: 5590243)
1. Studies on hypercoagulable state. II. The application of 131I-labelled fibrinogen for the estimation of intravascular coagulation in human subjects.
Izak G; Galewski K; Eyal Z
Thromb Diath Haemorrh; 1967 Dec; 18(3-4):544-51. PubMed ID: 5590243
[No Abstract] [Full Text] [Related]
2. [Incorporation of I-125 labelled fibrinogen. Study in normal subjects].
Langer B; Camargo EE; Mário J; dos Reis M; Carvalho N; Leão LE
Rev Hosp Clin Fac Med Sao Paulo; 1976; 31(2):99-104. PubMed ID: 1265379
[No Abstract] [Full Text] [Related]
3. The effect of oral contraceptives on factor VIII levels.
Crowell EB; Clatanoff DV; Kiekhofer W
J Lab Clin Med; 1971 Apr; 77(4):551-7. PubMed ID: 5554340
[No Abstract] [Full Text] [Related]
4. Nephrotic syndrome. A hypercoagulable state.
Kendall AG; Lohmann RC; Dossetor JB
Arch Intern Med; 1971 Jun; 127(6):1021-7. PubMed ID: 5578557
[No Abstract] [Full Text] [Related]
5. Detection of hypercoagulable states with protamine sulphate tests.
Lipinski B
Acta Univ Carol Med Monogr; 1972; 52():185-8. PubMed ID: 4273929
[No Abstract] [Full Text] [Related]
6. Use of I-125-fibrinogen for determination of intravascular coagulation in vivo in various organs in the dog.
Busch C; Lundqvist H; Saldeen T
Acta Pathol Microbiol Scand A; 1970; 78(4):492. PubMed ID: 5476629
[No Abstract] [Full Text] [Related]
7. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
8. [Metabolism and localization of I 131-fibrinogen in chronic intravascular coagulation].
Straub PW; Kessler S
Schweiz Med Wochenschr; 1970 Nov; 100(46):2001-3. PubMed ID: 5507850
[No Abstract] [Full Text] [Related]
9. Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
Zetterqvist E
Acta Physiol Scand Suppl; 1969; 325():1-41. PubMed ID: 4900570
[No Abstract] [Full Text] [Related]
10. [Diagnosis of the prethrombotic state in clinical practice].
Makatsariia AD; Mishchenko AL
Sov Med; 1982; (6):56-60. PubMed ID: 6750807
[No Abstract] [Full Text] [Related]
11. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
[TBL] [Abstract][Full Text] [Related]
12. [Distribution and turnover of fibrinogen labelled with I-125 in atherosclerotic subjects].
Cajozzo A; Indovina I; Carreca I
Haematologica; 1971; 56(11):479-87. PubMed ID: 5004756
[No Abstract] [Full Text] [Related]
13. [Changes in coagulation in patients with sepsis].
Alarcón G; Fardella P; Conte G; Vargas V; Parada X; Cuneo M
Rev Med Chil; 1993 May; 121(5):537-41. PubMed ID: 8272635
[TBL] [Abstract][Full Text] [Related]
14. [Blood coagulation changes caused by diagnostic and therapeutic dosage of I-131. II. Therapeutic dose (5 mC)].
Nenci GG; Casamassima F; Notaristefano A
Riv Patol Clin Sper; 1969; 10(2):107-12. PubMed ID: 5398166
[No Abstract] [Full Text] [Related]
15. Clinical and laboratory evaluation of the hypercoagulable states.
Macik BG; Ortel TL
Clin Chest Med; 1995 Jun; 16(2):375-87. PubMed ID: 7656547
[TBL] [Abstract][Full Text] [Related]
16. An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland.
Forman WB; Ratnoff OD; Boyer MH
J Lab Clin Med; 1968 Sep; 72(3):455-72. PubMed ID: 5674077
[No Abstract] [Full Text] [Related]
17. [Congenital dysfibrinogenemia. Apropos of 13 cases].
Corrihons G; Soria J; Soria C; Conard J; Horellou MH; Samama M
Sem Hop; 1983 Oct; 59(36):2517-23. PubMed ID: 6316508
[TBL] [Abstract][Full Text] [Related]
18. [Does D-dimer help when blood coagulates?].
Lassila R
Duodecim; 1999; 115(24):2707-9. PubMed ID: 11979609
[No Abstract] [Full Text] [Related]
19. Metabolism of fibrinogen in cirrhosis of the liver.
Tytgat GN; Collen D; Verstraete M
South Med J; 1971 Oct; 64(10):1690-701. PubMed ID: 5125556
[No Abstract] [Full Text] [Related]
20. Coagulation changes in clinical shock. II. Effect of septic shock on clotting times and fibrinogen in humans.
Attar S; Mansberger AR; Irani B; Kirby W; Masaitis C; Cowley RA
Ann Surg; 1966 Jul; 164(1):41-50. PubMed ID: 5947293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
